Use separate syringes for each IM injection
Wegovy is not normally prescribed for diabetes control
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds (15 kilograms)
As advanced practice nurses, you should be completely transparent in the care of the transgender patient
Warnings and Precautions Tirzepatide carries an FDA black box warning regarding the potential risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), observed in rodent studies
At Rewind Anti-Aging of Miami, treatment plans are personalized based on comprehensive lab work, symptom evaluation, and individual goals